Rishi Raj

4.8/5

21 Patient Ratings

59 Patient Reviews

Rishi Raj

Pulmonologist

View Professional Summary

Additional Languages Spoken:

Hindi , Punjabi

Insurance Coverage

Resources for Referring Physicians

Biography

Dr. Rishi Raj is a Clinical Professor of Medicine at Stanford University, where he directs the Interstitial Lung Disease program. He has practiced pulmonary and critical care medicine for over two decades and specializes in the diagnosis and treatment of interstitial lung diseases.

His primary clinical interest encompasses a range of interstitial lung diseases, including idiopathic pulmonary fibrosis, other idiopathic interstitial lung diseases, drug-induced interstitial lung diseases, interstitial lung disease associated with connective tissue diseases such as scleroderma, rheumatoid arthritis, dermatomyositis, sarcoidosis, hypersensitivity pneumonitis, and other various interstitial lung diseases. His other clinical interest is acute respiratory failure associated with interstitial lung diseases, and Dr. Raj attends regularly in the medical intensive care units.

Dr. Raj's clinical research explores the use of radiologic biomarkers to predict outcomes in various interstitial lung diseases. He is a principal investigator and co-investigator in numerous clinical trials, examining new therapies for treating idiopathic pulmonary fibrosis and other interstitial lung diseases.

Dr. Raj's current research focuses on leveraging large language models in clinical research.

View Full Biography

Professional Summary

Education & Certifications

Medical Education: Christian Medical College Vellore (1995) India
Board Certification: American Board of Internal Medicine, Pulmonary Disease (2024)
Fellowship: Baylor College of Medicine (2002) TX
- Board Certification: American Board of Internal Medicine, Critical Care Medicine (2003)
- Residency: Texas Tech University Health Sciences Center (1999) TX

View More Education & Certifications

Administrative Appointments

Director, Interstitial Lung Disease Program, Stanford (2017 - Present)

Publications

Rituximab Versus Mycophenolate Mofetil in Interstitial Lung Disease Secondary to Connective Tissue Disease
Zhu, L., Li, S., Gagne, L., Jacobs, S., Morisset, J., Mooney, J., … Chung, L. (2018). Rituximab Versus Mycophenolate Mofetil in Interstitial Lung Disease Secondary to Connective Tissue Disease. ARTHRITIS & RHEUMATOLOGY, 70.
Tissue Continues to Be the Issue Role of Histopathology in the Context of Recent Updates in the Radiologic Classification of Interstitial Lung Diseases
Raparia, K., & Raj, R. (2019). Tissue Continues to Be the Issue Role of Histopathology in the Context of Recent Updates in the Radiologic Classification of Interstitial Lung Diseases. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 143(1), 30–33.
Tissue Continues to Be the Issue: Role of Histopathology in the Context of Recent Updates in the Radiologic Classification of Interstitial Lung Diseases.
Raparia, K., & Raj, R. (2019). Tissue Continues to Be the Issue: Role of Histopathology in the Context of Recent Updates in the Radiologic Classification of Interstitial Lung Diseases. Archives of Pathology & Laboratory Medicine, 143(1), 30–33.
- Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry
  Snyder, L., Neely, M. L., Hellkamp, A. S., O'Brien, E., de Andrade, J., Conoscenti, C. S., … Whelan, T. P. (2019). Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry. RESPIRATORY RESEARCH, 20, 105.
- Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
  Todd, J. L., Neely, M. L., Overton, R., Durham, K., Gulati, M., Huang, H., … Whelan, T. P. (2019). Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry. RESPIRATORY RESEARCH, 20(1), 227.
- Survival implications of pulmonary hypertension in end-stage COPD
  Kapasi, A., Halloran, K., Hirji, A., Lien, D., Mooney, J., Raj, R., … Zamanian, R. (2019). Survival implications of pulmonary hypertension in end-stage COPD. EUROPEAN RESPIRATORY JOURNAL. EUROPEAN RESPIRATORY SOC JOURNALS LTD.
- Elevated pulmonary vascular resistance is associated with increased risk of death in IPF
  Kapasi, A., Halloran, K., Hirji, A., Lien, D., Mooney, J., Raj, R., … Zamanian, R. (2019). Elevated pulmonary vascular resistance is associated with increased risk of death in IPF. EUROPEAN RESPIRATORY JOURNAL. EUROPEAN RESPIRATORY SOC JOURNALS LTD.
- Sleep Patterns and Health Behaviors in Healthcare Students.
  Nugent, K., Raj, R., & Nugent, R. (2020). Sleep Patterns and Health Behaviors in Healthcare Students. Southern Medical Journal, 113(3), 104–10.
- Vaping-related Acute Parenchymal Lung Injury: A Systematic Review.
  Jonas, A. M., & Raj, R. (2020). Vaping-related Acute Parenchymal Lung Injury: A Systematic Review. Chest.
- Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease-Associated Interstitial Lung Disease.
  Zhu, L., Chung, M. P., Gagne, L., Guo, H. H., Guenther, Z., Li, S., … Chung, L. (2020). Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease-Associated Interstitial Lung Disease. ACR Open Rheumatology.
- A piece of my mind. Crossing over.
  Raj, R. (1997). A piece of my mind. Crossing over. JAMA, 278(21), 1721.
- Human immunodeficiency virus infections in adolescents.
  Raj, R., & Verghese, A. (2000). Human immunodeficiency virus infections in adolescents. Adolescent Medicine (Philadelphia, Pa.), 11(2), 359–74.
- Scedosporium apiospermum fungemia in a lung transplant recipient.
  Raj, R., & Frost, A. E. (2002). Scedosporium apiospermum fungemia in a lung transplant recipient. Chest, 121(5), 1714–6.
- Systemic lupus erythematosus in the intensive care unit.
  Raj, R., Murin, S., Matthay, R. A., & Wiedemann, H. P. (2002). Systemic lupus erythematosus in the intensive care unit. Critical Care Clinics, 18(4), 781–803.
- Effect of the new Medicare guideline on patient qualification for positive airway pressure therapy.
  Raj, R., & Hirshkowitz, M. (2003). Effect of the new Medicare guideline on patient qualification for positive airway pressure therapy. Sleep Medicine, 4(1), 29–33.
- Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
  Raj, R., & Frost, A. E. (2005). Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation, 24(6), 671–9.
- Advanced locally invasive squamous cell carcinoma.
  Pankratz, M. M., Chandler, R., Otahbachi, M., Nugent, K., & Raj, R. (2009). Advanced locally invasive squamous cell carcinoma. The American Journal of the Medical Sciences, 338(1), 68.
- One hundred-foot walk test for functional assessment of clinic patients.
  Raj, R., Guerra, D., Sehli, S., Nipp, R., Perdue, N., Alalawi, R., … Nugent, K. (2009). One hundred-foot walk test for functional assessment of clinic patients. The American Journal of the Medical Sciences, 338(5), 361–67.
- Novel swine-origin (S-OIV) H1N1 influenza A pneumonia in a lung transplant patient: a case report and review of the literature on performance characteristics of rapid screening tests for the S-OIV.
  Raj, R., Cerdan, M., Yepeshurtado, A., Kimbrough, R., & Nugent, K. (2009). Novel swine-origin (S-OIV) H1N1 influenza A pneumonia in a lung transplant patient: a case report and review of the literature on performance characteristics of rapid screening tests for the S-OIV. The American Journal of the Medical Sciences, 338(6), 506–8.
- Amiodarone-induced loculated pleural effusion: case report and review of the literature.
  Uong, V., Nugent, K., Alalawi, R., & Raj, R. (2010). Amiodarone-induced loculated pleural effusion: case report and review of the literature. Pharmacotherapy, 30(2), 218.
- Obstructive sleep apnea and respiratory complications associated with vagus nerve stimulators.
  Parhizgar, F., Nugent, K., & Raj, R. (2011). Obstructive sleep apnea and respiratory complications associated with vagus nerve stimulators. Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine, 7(4), 401–7.
- Prolonged acute care in a 52-year-old man with respiratory failure: lessons learned from 70-day intensive care unit hospitalization.
  Mishra, R. K., Alalawi, R., Raj, R., & Nugent, K. M. (2011). Prolonged acute care in a 52-year-old man with respiratory failure: lessons learned from 70-day intensive care unit hospitalization. Journal of Critical Care, 26(5), 532.e9–532.e16.
- Hyperthyroidism and pulmonary hypertension: an important association.
  Vallabhajosula, S., Radhi, S., Cevik, C., Alalawi, R., Raj, R., & Nugent, K. (2011). Hyperthyroidism and pulmonary hypertension: an important association. The American Journal of the Medical Sciences, 342(6), 507–12.
- Risk factors of Candida colonization in the oropharynx of patients admitted to an intensive care unit.
  Mojazi Amiri, H., Frandah, W., Colmer-Hamood, J., Raj, R., & Nugent, K. (2012). Risk factors of Candida colonization in the oropharynx of patients admitted to an intensive care unit. Journal De Mycologie Medicale, 22(4), 301–7.
- Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive care unit.
  Frandah, W., Colmer-Hamood, J., Nugent, K., & Raj, R. (2012). Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive care unit. Journal of Intensive Care Medicine, 29(2), 96–103.
- Oropharyngeal flora in patients admitted to the medical intensive care unit: clinical factors and acid suppressive therapy.
  Frandah, W., Colmer-Hamood, J., Mojazi Amiri, H., Raj, R., & Nugent, K. (2013). Oropharyngeal flora in patients admitted to the medical intensive care unit: clinical factors and acid suppressive therapy. Journal of Medical Microbiology, 62(Pt 5), 778–84.
- Refractory IgG4-related lung disease with constitutional symptoms and severe inflammation.
  Sun, X., Peng, M., Hou, X., Feng, R., & Xu, Z. (2014). Refractory IgG4-related lung disease with constitutional symptoms and severe inflammation. American Journal of Respiratory and Critical Care Medicine, 189(3), 374–5.
- Reply: Refractory IgG4-related lung disease with constitutional symptoms and severe inflammation.
  Raj, R. (2014). Reply: Refractory IgG4-related lung disease with constitutional symptoms and severe inflammation. American Journal of Respiratory and Critical Care Medicine, 189(3), 375–6.
- The repeatability of gait speed and physiological cost index measurements in working adults.
  Raj, R., Mojazi Amiri, H., Wang, H., & Nugent, K. M. (2014). The repeatability of gait speed and physiological cost index measurements in working adults. Journal of Primary Care & Community Health, 5(2), 128–33.
- Characterization of sleep patterns and problems in healthcare workers in a tertiary care hospital.
  Buscemi, D., Anvari, R., Raj, R., & Nugent, K. (2014). Characterization of sleep patterns and problems in healthcare workers in a tertiary care hospital. Southern Medical Journal, 107(1), 11–16.
- Modeling the relation between obesity and sleep parameters in children referred for dietary weight reduction intervention.
  Nugent, R., Althouse, A., Yaqub, Y., Nugent, K., & Raj, R. (2014). Modeling the relation between obesity and sleep parameters in children referred for dietary weight reduction intervention. Southern Medical Journal, 107(8), 473–80.
- Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.
  Villa, C., Cagle, P. T., Johnson, M., Patel, J. D., Yeldandi, A. V., Raj, R., … Raparia, K. (2014). Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society. Archives of Pathology & Laboratory Medicine, 138(10), 1353–7.
- Accelerometer-based devices can be used to monitor sedation/agitation in the intensive care unit.
  Raj, R., Ussavarungsi, K., & Nugent, K. (2014). Accelerometer-based devices can be used to monitor sedation/agitation in the intensive care unit. Journal of Critical Care, 29(5), 748–52.
- Bladder Pressure Measurements in Patients Admitted to a Medical Intensive Care Unit.
  Anvari, E., Nantsupawat, N., Gard, R., Raj, R., & Nugent, K. (2015). Bladder Pressure Measurements in Patients Admitted to a Medical Intensive Care Unit. The American Journal of the Medical Sciences, 350(3), 181–85.
- The Frequency of Frailty in Ambulatory Patients With Chronic Lung Diseases.
  Mittal, N., Raj, R., Islam, E. A., & Nugent, K. (2016). The Frequency of Frailty in Ambulatory Patients With Chronic Lung Diseases. Journal of Primary Care & Community Health, 7(1), 10–15.
- Peripheral lung adenocarcinomas with KRAS mutations are more likely to invade visceral pleura.
  Raparia, K., Villa, C., Raj, R., & Cagle, P. T. (2015). Peripheral lung adenocarcinomas with KRAS mutations are more likely to invade visceral pleura. Archives of Pathology & Laboratory Medicine, 139(2), 189–93.
- Low-dose oral interferon a possibly retards the progression of idiopathic pulmonary fibrosis and alleviates associated cough in some patients.
  Lutherer, L. O., Nugent, K. M., Schoettle, B. W., Cummins, M. J., Raj, R., Birring, S. S., & Jumper, C. A. (2011). Low-dose oral interferon a possibly retards the progression of idiopathic pulmonary fibrosis and alleviates associated cough in some patients. Thorax, 66(5), 446–47.
- Lenalidomide-induced interstitial lung disease.
  Chen, Y., Kiatsimkul, P., Nugent, K., & Raj, R. (2010). Lenalidomide-induced interstitial lung disease. Pharmacotherapy, 30(3), 325.
- Sirolimus induced granulomatous interstitial pneumonitis.
  Ussavarungsi, K., Elsanjak, A., Laski, M., Raj, R., & Nugent, K. (2012). Sirolimus induced granulomatous interstitial pneumonitis. Respiratory Medicine Case Reports, 7, 8–11.
- Leflunomide-induced interstitial lung disease (a systematic review).
  Raj, R., & Nugent, K. (2013). Leflunomide-induced interstitial lung disease (a systematic review). Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG, 30(3), 167–76.
- IgG4-related lung disease.
  Raj, R. (2013). IgG4-related lung disease. American Journal of Respiratory and Critical Care Medicine, 188(5), 527–9.
- Hyperacute Methotrexate Pneumonitis in a Patient With Crohn's Disease.
  Trivedi, I., Raj, R., & Hanauer, S. (2016). Hyperacute Methotrexate Pneumonitis in a Patient With Crohn's Disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association, 14(3), A29–30.
- Mortality Related to Surgical Lung Biopsy in Patients with Interstitial Lung Disease. The Devil Is in the Denominator.
  Raj, R., & Brown, K. K. (2016). Mortality Related to Surgical Lung Biopsy in Patients with Interstitial Lung Disease. The Devil Is in the Denominator. American Journal of Respiratory and Critical Care Medicine, 193(10), 1082–4.
- Surgical Lung Biopsy for Interstitial Lung Diseases.
  Raj, R., Raparia, K., Lynch, D. A., & Brown, K. K. (2017). Surgical Lung Biopsy for Interstitial Lung Diseases. Chest, 151(5), 1131–1140.
- Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry.
  O'Brien, E. C., Hellkamp, A. S., Neely, M. L., Swaminathan, A., Bender, S., Snyder, L. D., … Leonard, T. B. (2020). Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry. Chest, 157(5), 1188–1198.
- Unusual pulmonary complication from Maloney dilation
  Hodges, D. S., & Raj, R. (2007). Unusual pulmonary complication from Maloney dilation. AMERICAN JOURNAL OF GASTROENTEROLOGY, 102, S417.
- Numerical Simulations of High-Frequency Respiratory Flows in 2D and 3D Lung Bifurcation Models
  Chen, Z., Parameswaran, S., Hu, Y., He, Z., Raj, R., & Parameswaran, S. (2014). Numerical Simulations of High-Frequency Respiratory Flows in 2D and 3D Lung Bifurcation Models. INTERNATIONAL JOURNAL FOR COMPUTATIONAL METHODS IN ENGINEERING SCIENCE & MECHANICS, 15(4), 337–44.
- Vagus nerve stimulator-induced apneas and hypopneas in a child with refractory seizures
  Parhizgar, F., Rogers, K., Hurst, D., Nugent, K., & Raj, R. (2012). Vagus nerve stimulator-induced apneas and hypopneas in a child with refractory seizures. JOURNAL OF PEDIATRIC NEUROLOGY, 10(1), 53–56.
- Abdominal Wall Hematoma Following Paracentesis
  Islam, S., Islam, E., Nugent, K., & Raj, R. (2010). Abdominal Wall Hematoma Following Paracentesis. AMERICAN JOURNAL OF GASTROENTEROLOGY, 105, S278–S279.
- The Role of Surgical Lung Biopsy in the Diagnosis of Fibrotic Interstitial Lung Disease: Perspective from the Pulmonary Fibrosis Foundation.
  Hariri, L. P., Roden, A. C., Chung, J. H., Danoff, S. K., Gomez Manjarres, D. C., Hartwig, M., … Ley, B. (2021). The Role of Surgical Lung Biopsy in the Diagnosis of Fibrotic Interstitial Lung Disease: Perspective from the Pulmonary Fibrosis Foundation. Annals of the American Thoracic Society.
- Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): clinical characteristics and progression to carcinoid tumor.
  Yang Sun, T., Hwang, G., Pancirer, D., Hornbacker, K., Codima, A., Lui, N. S., … Padda, S. K. (2021). Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): clinical characteristics and progression to carcinoid tumor. The European Respiratory Journal.
- Prescription Patterns for Pulmonary Vasodilators in the Treatment of Pulmonary Hypertension Associated With Chronic Lung Diseases: Insights From a Clinician Survey.
  Thomas, C. A., Lee, J., Bernardo, R. J., Anderson, R. J., Glinskii, V., Sung, Y. K., … de Jesus Perez, V. (1800). Prescription Patterns for Pulmonary Vasodilators in the Treatment of Pulmonary Hypertension Associated With Chronic Lung Diseases: Insights From a Clinician Survey. Frontiers in Medicine, 8, 764815.
- COVID-19 mRNA Vaccines and ILD Exacerbation: Causation or Just a Temporal Association?
  Ehteshami-Afshar, S., & Raj, R. (2022). COVID-19 mRNA Vaccines and ILD Exacerbation: Causation or Just a Temporal Association? American Journal of Respiratory and Critical Care Medicine.
- Diffuse Panbronchiolitis in a Patient With Ulcerative Colitis Treated With Ustekinumab.
  Marmor, M., Berry, G., & Raj, R. (2023). Diffuse Panbronchiolitis in a Patient With Ulcerative Colitis Treated With Ustekinumab. ACG Case Reports Journal, 10(5), e01062.
- Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
  Maher, T. M., Ford, P., Brown, K. K., Costabel, U., Cottin, V., Danoff, S. K., … Wijsenbeek, M. S. (2023). Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials. JAMA, 329(18), 1567–1578.
- Exploring the Versatility of Zero-Shot CLIP for Interstitial Lung Disease Classification
  Uden, C. V., Bluethgen, C., Attis, M., Polacin, M., Guo, H. H., Simha, N., … Langlotz, C. (2023). Exploring the Versatility of Zero-Shot CLIP for Interstitial Lung Disease Classification. arXiv: arXiv. Retrieved from https://arxiv.org/abs/2306.01111
- Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression.
  Ruan, P., Todd, J. L., Zhao, H., Liu, Y., Vinisko, R., Soellner, J. F., … Salisbury, M. L. (2023). Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression. Respiratory Research, 24(1), 141.
- A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis.
  Baker, M. C., Horomanski, A., Wang, Y., Yuhan, L., Parsafar, S., Fairchild, R., … Genovese, M. C. (2023). A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis. Rheumatology (Oxford, England).
- Lung function trajectories in patients with idiopathic pulmonary fibrosis.
  Neely, M. L., Hellkamp, A. S., Bender, S., Todd, J. L., Liesching, T., Luckhardt, T. R., … Palmer, S. M. (2023). Lung function trajectories in patients with idiopathic pulmonary fibrosis. Respiratory Research, 24(1), 209.
- Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts.
  Maddali, M. V., Moore, A. R., Sinha, P., Newton, C. A., Kim, J. S., Adegunsoye, A., … Oldham, J. M. (2024). Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts. American Journal of Respiratory and Critical Care Medicine.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Practice Locations

,

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(21 Ratings)

Overall Rating

4.8/5

View Ratings by Category

4.8/5

Friendliness

4.9/5

Explanations

4.9/5

Listens

4.8/5

Care provider's efforts to include you in decisions about your care

4.9/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(59 reviews)

Had a great informative appointment.

Sep 2024

•

Verified SHC Patient

Dr, Raj is the epitome of kindness and compassion, So grateful to be under his care.

Aug 2024

•

Verified SHC Patient

Excellent was very informative and helpful and detailed discussion

May 2024

•

Verified SHC Patient

My video visit was just like being there (except for blood pressure check and lungs being listen to)....test results were shown on screen etc.

Sep 2023

•

Verified SHC Patient

Excellent communicator. Kind, thoughtful and caring.

Aug 2023

•

Verified SHC Patient

Always on time, and never feel rushed. Doctor Raj always listens to everything I say and is very clear in his thoughts and direction.

Mar 2023

•

Verified SHC Patient

I appreciate his knowledge and understanding of my health....

Feb 2023

•

Verified SHC Patient

The video visit was fine...ALM,OST like being there....

Aug 2022

•

Verified SHC Patient

Dr. Raj is extremely thorough and thoughtful. I feel confident to have him as my physician.

Jul 2022

•

Verified SHC Patient

I was very impressed with the doctors, technicians, the efficiency of the system and the friendly service received!

Jul 2022

•

Verified SHC Patient

Everything was excellent!

Jul 2022

•

Verified SHC Patient

Heâ€™s thorough and efficient. Heâ€™s articulate in his instructions for follow up.

May 2022

•

Verified SHC Patient

Very efficient, on time and friendly.

Apr 2022

•

Verified SHC Patient

Dr was great, but took 4 months to see a,Pulmonologist! A systematic problem at Stanford, for specialists,.

Apr 2022

•

Verified SHC Patient

Excellent pulmonist.

Mar 2022

•

Verified SHC Patient

Excellent experience

Feb 2022

•

Verified SHC Patient

I love the multidiscipline that I received from Stanford....

Feb 2022

•

Verified SHC Patient

He did an excellent job of explaining any questions or concerns that I have

Jan 2022

•

Verified SHC Patient

excellant ...excelant....

Jan 2022

•

Verified SHC Patient

Seemed to be very Thorough. Hopefully he will be able to figure it out.

Dec 2021

•

Verified SHC Patient

Overall very satisfied.

Sep 2021

•

Verified SHC Patient

Dr. Raj and his team are outstanding

Sep 2021

•

Verified SHC Patient

Very helpful and friendly staff.

Jun 2021

•

Verified SHC Patient

I have nothing but good words for Stanford Health Care and am a substantial donor.

Jun 2021

•

Verified SHC Patient

Dr. Raj is tops in his field.

Jun 2021

•

Verified SHC Patient

Dr. Raj is the best! He listens well. He answers our questions. He explains to our understanding.

Feb 2021

•

Verified SHC Patient

I never felt rushed & got all my questions answered. Everything was explained well.

Feb 2021

•

Verified SHC Patient

Dr. Raj is outstanding!

Jan 2021

•

Verified SHC Patient

My experience has always been very good.

Dec 2020

•

Verified SHC Patient

The dr. and assistant also are very nice.

Dec 2020

•

Verified SHC Patient

Very through & very articulate with explanation and options for treatment, honest in his approach. Very calming with made me feel supported.

Oct 2020

•

Verified SHC Patient

entire staff was well trained from the front door to Dr Raj. Truly the best medical experience I have received.

Jun 2020

•

Verified SHC Patient

I was seen by the PA and after 20 minutes I saw my doctor who only spent spent 5 minutes. I do feel he is too busy to care for me

Feb 2020

•

Verified SHC Patient

I felt frustrated for not speaking the English language but they have a good interpreting program .

Nov 2019

•

Verified SHC Patient

every one awesome

Sep 2019

•

Verified SHC Patient

Very comprehensive & thorough.

Sep 2019

•

Verified SHC Patient

I highly recommend Dr. Raj.

Aug 2019

•

Verified SHC Patient

They tell you when you will be seen again and do ask if I have any Q.

Jun 2019

•

Verified SHC Patient

I feel confident that I am getting the best care available for my health condition.

Jun 2019

•

Verified SHC Patient

We appreciated that Dr. Raj was going to discuss Jack's case with his local pulmonologist.

Mar 2019

•

Verified SHC Patient

Love Dr. Raj & his intern that came in before Dr. Raj on this visit. Very animated & easy to talk too - seemed genuinely interested in my case.

Mar 2019

•

Verified SHC Patient

Good!

Feb 2019

•

Verified SHC Patient

Dr. Raj is great at helping me with my illness. His... also great. Excellent follow up to all of my questions.

Feb 2019

•

Verified SHC Patient

I like that there is a team of doctors who come together to confirm findings & treatment that is best for me.

Feb 2019

•

Verified SHC Patient

English is my second language and it is always hard to understand the medical terminology.

Dec 2018

•

Verified SHC Patient

Very good session.

Nov 2018

•

Verified SHC Patient

The whole staff I saw was excellent!

Sep 2018

•

Verified SHC Patient

Dr. Raj was wonderful. Very pleased with him.

Sep 2018

•

Verified SHC Patient

Dr. Raj is the BEST!

Aug 2018

•

Verified SHC Patient

The doctor and staff are always very helpful and friendly.

Aug 2018

•

Verified SHC Patient

I feel that my health problems were studied and their answers were explained very well to me and my husband. I especially liked the written report that I received. I didn't have to rely on my memory of the visit. This was the best explanation I've ever received about my lung condition.

Jul 2018

•

Verified SHC Patient

Everything was explained very carefully and my question were answered.

Jul 2018

•

Verified SHC Patient

I believe I am getting the best care possible.

May 2018

•

Verified SHC Patient

Care providers were very polite and I feel comfortable they are taking good care of me.

May 2018

•

Verified SHC Patient

Dr. Raj is excellent! Very knowledgeable and an expert. He is very caring and takes into consideration patient's input.

May 2018

•

Verified SHC Patient

I am content with the entire staff especially the Dr. Raj.

Apr 2018

•

Verified SHC Patient

Dr. Raj is excellent! However, I felt that the student/dr. in training seemed a bit impatient with my questions. She almost seemed irritated that I even asked questions.

Mar 2018

•

Verified SHC Patient

4. No treatment plan yet.

Mar 2018

•

Verified SHC Patient

Bad experience in that dr. wanted me to use oxygen.

Jan 2018

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Rishi Raj

Pulmonologist

Get In Touch

Biography

Professional Summary

Education & Certifications

Administrative Appointments

Publications

Clinical Trials

Practice Locations

,

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(59 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Rishi Raj

Pulmonologist

Get In Touch

Biography

Professional Summary

Education & Certifications

Administrative Appointments

Publications

Clinical Trials

Practice Locations

,

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(59 reviews)

Referring Physicians

PHYSICIAN HELPLINE